Is Wilsons disease hereditary?

Wilson’s disease is strictly a hereditary genetic condition, meaning it is passed from parents to children through DNA rather than being acquired later in life. It follows an autosomal recessive inheritance pattern, which means an individual must inherit two copies of the mutated ATP7B gene—one from each parent—to develop the disease.

Is Wilson’s disease strictly hereditary?

Yes, Wilson’s disease is a hereditary disorder caused by mutations in the ATP7B gene, which is located on chromosome 13. Because it is an autosomal recessive condition, it is strictly genetic and cannot be contracted through environmental exposure or infection. While a person may be a "carrier" if they possess only one mutated copy of the gene, they will generally remain asymptomatic, as the body can compensate with the single functional copy. Wilson’s disease only manifests when both inherited copies of the gene are non-functional, leading to the toxic accumulation of copper in the liver, brain, and other vital organs.

What is the risk for children of affected parents?

When both parents are carriers of the ATP7B mutation, the probability of their children inheriting Wilson’s disease follows standard Mendelian inheritance ratios for autosomal recessive traits:

• 25% chance for each child to inherit two mutated genes and develop Wilson’s disease.


• 50% chance for each child to inherit one mutated gene and become an asymptomatic carrier.


• 25% chance for each child to inherit two normal genes, meaning they are neither affected nor a carrier.

If an individual already has Wilson’s disease, all of their children will at least be carriers, as they will pass on one copy of the mutated gene to every offspring.

Are de novo mutations common in Wilson’s disease?

De novo (spontaneous) mutations—where the disease appears in a child without a family history—are exceptionally rare in Wilson’s disease. The vast majority of cases are inherited from parents who are asymptomatic carriers. Because Wilson’s disease is relatively rare (affecting approximately 1 in 30,000 to 1 in 50,000 people globally), it is common to find no family history of the condition, leading many families to mistakenly believe it is not hereditary.

How is genetic testing and counseling utilized?

Genetic testing for Wilson’s disease involves molecular analysis of the ATP7B gene to identify specific pathogenic variants. This is highly recommended for siblings and first-degree relatives of a newly diagnosed patient, as early detection allows for life-saving preventative treatment before symptoms emerge. Genetic counseling is an essential component of this process, as it helps families understand the inheritance risks, explains the options for carrier screening, and provides guidance for those planning pregnancies. In cases where both partners are known carriers, options such as preimplantation genetic testing (PGT) or prenatal diagnosis via amniocentesis may be discussed.

Next steps

• Consult with a clinical geneticist to discuss whether your family history warrants ATP7B gene sequencing.


• If you have a relative with Wilson’s disease, speak to your physician about screening your copper levels and ceruloplasmin levels.


• Join the DiseaseMaps.org community to connect with 161+ members who share experiences and insights on managing this condition.


• Request a referral to a hepatologist or metabolic specialist if you suspect symptoms of copper toxicity.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet (ORPHA:905)


• NIH Genetic and Rare Diseases Information Center (GARD)


• Online Mendelian Inheritance in Man (OMIM #277900)


• Wilson Disease Association